Low taxes on foreign-made drugs that are not manufactured locally. Expanding public health insurance coverage boosting demand for generic medicines. ...Expanding public health insurance coverage boosting demand for generic medicines. Improved international relations may increase confidence of multinational drugmakers to invest in the market. Increased investment in local pharmaceutical capacities. ...Construction of private pharmaceutical city to house --- companies.
...In August ----, Vice President for Science and Technology Sorena Sattari announced plans for Iran to commence the exporting of pharmaceuticals to Europe. The plan comes both as a result of Iran s ability of satisfying almost all internal demand with domestic production (-- ) and greater opportunities for trade post-sanctions. ...The plan comes both as a result of Iran s ability of satisfying almost all internal demand with domestic production (-- ) and greater opportunities for trade post-sanctions. � In August ----, Iranian and Swedish government representatives met to discuss expanding economic cooperation, particularly in the areas of pharmaceutical industries and medical equipment and infrastructure. As part of the negotiations, officials from both sides agreed to examine the feasibility of a joint construction hospital project in Tehran. ...� In August ----, Iranian and Swedish government representatives met to discuss expanding economic cooperation, particularly in the areas of pharmaceutical industries and medical equipment and infrastructure. As part of the negotiations, officials from both sides agreed to examine the feasibility of a joint construction hospital project in Tehran.
...Iran scores --.- out of --- in terms of its attractiveness as a destination to launch innovative pharmaceuticals in Q---, maintaining its score from the previous quarter, according to BMI s Risk/Reward Index. Iran s position in the index remains stationary at --th out of -- countries in the Middle East and Africa region. Its overall score currently sits exactly at the regional average of --.-. Generally speaking, Iran benefits from a large and growing population and relatively widespread access to healthcare services. However, its regulatory regime - including intellectual property rights and economic ...